138 related articles for article (PubMed ID: 16444179)
1. Growth in disorders of adrenal hyperfunction.
Magiakou MA
Pediatr Endocrinol Rev; 2004 Aug; 1 Suppl 3():484-9. PubMed ID: 16444179
[TBL] [Abstract][Full Text] [Related]
2. Growth in disorders of adrenal hyperfunction.
Savage MO; Scommegna S; Carroll PV; Ho JT; Monson JP; Besser GM; Grossman AB
Horm Res; 2002; 58 Suppl 1():39-43. PubMed ID: 12373013
[TBL] [Abstract][Full Text] [Related]
3. Growth patterns and outcomes in congenital adrenal hyperplasia; effect of chronic treatment regimens.
Rasat R; Espiner EA; Abbott GD
N Z Med J; 1995 Aug; 108(1005):311-4. PubMed ID: 7644165
[TBL] [Abstract][Full Text] [Related]
4. Growth abnormalities associated with adrenal disorders and their management.
Savage MO; Lebrethon MC; Blair JC; Ho JT; Johnston LB; Lienhardt A; Clark AJ; Chaussain JL
Horm Res; 2001; 56 Suppl 1():19-23. PubMed ID: 11786680
[TBL] [Abstract][Full Text] [Related]
5. [11beta-hydroxylase deficiency: improvement of final height with growth hormone and gonadotropin-releasing hormone analog].
Orío Hernández M; Yebra Yebra J; Bezanilla López C; Gracia Bouthelier R
An Pediatr (Barc); 2007 Aug; 67(2):153-6. PubMed ID: 17692261
[TBL] [Abstract][Full Text] [Related]
6. Growth in children with adrenocortical tumors.
Hauffa BP; Roll C; Mühlenberg R; Havers W
Klin Padiatr; 1991; 203(2):83-7. PubMed ID: 2033910
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of final height in patients with pituitary growth hormone deficiency who were treated with growth hormone replacement].
Korpal-Szczyrska M; Dorant B; Kamińska H; Birkholz D; Niedźwiecki M
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):31-4. PubMed ID: 16704859
[TBL] [Abstract][Full Text] [Related]
8. Growth pattern and final height in 21-hydroxylase deficiency.
Bajpai A; Pandey RM; Kabra M; Menon PS
Indian Pediatr; 2007 Oct; 44(10):771-3. PubMed ID: 17998577
[TBL] [Abstract][Full Text] [Related]
9. Absence of increased height velocity in the first year of life in untreated children with simple virilizing congenital adrenal hyperplasia.
Claahsen-van der Grinten HL; Noordam K; Borm GF; Otten BJ
J Clin Endocrinol Metab; 2006 Apr; 91(4):1205-9. PubMed ID: 16464952
[TBL] [Abstract][Full Text] [Related]
10. Hypercortisolism in childhood: shortcomings of conventional diagnostic criteria.
Streeten DH; Faas FH; Elders MJ; Dalakos TG; Voorhess M
Pediatrics; 1975 Nov; 56(5):797-803. PubMed ID: 1196738
[TBL] [Abstract][Full Text] [Related]
11. Growth pattern and skeletal maturation following growth hormone therapy in growth hormone deficiency: factors influencing outcome.
Bajpai A; Kabra M; Gupta AK; Menon PS
Indian Pediatr; 2006 Jul; 43(7):593-9. PubMed ID: 16891678
[TBL] [Abstract][Full Text] [Related]
12. Height gains in response to growth hormone treatment to final height are similar in patients with SHOX deficiency and Turner syndrome.
Blum WF; Cao D; Hesse V; Fricke-Otto S; Ross JL; Jones C; Quigley CA; Binder G
Horm Res; 2009; 71(3):167-72. PubMed ID: 19188742
[TBL] [Abstract][Full Text] [Related]
13. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
Resmini E; Minuto F; Colao A; Ferone D
Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
[TBL] [Abstract][Full Text] [Related]
14. A review of the effects of therapy on growth and bone mineralization in children with congenital adrenal hyperplasia.
Gallagher MP; Levine LS; Oberfield SE
Growth Horm IGF Res; 2005 Jul; 15 Suppl A():S26-30. PubMed ID: 16039891
[TBL] [Abstract][Full Text] [Related]
15. [Role of cortisol hypersecretion in the pathogenesis of osteoporosis].
Chiodini I; Scillitani A
Recenti Prog Med; 2008 Jun; 99(6):309-13. PubMed ID: 18710063
[TBL] [Abstract][Full Text] [Related]
16. Normal growth spurt and final height despite low levels of all forms of circulating insulin-like growth factor-I in a patient with acid-labile subunit deficiency.
Domené HM; Martínez AS; Frystyk J; Bengolea SV; Ropelato MG; Scaglia PA; Chen JW; Heuck C; Wolthers OD; Heinrich JJ; Jasper HG
Horm Res; 2007; 67(5):243-9. PubMed ID: 17213728
[TBL] [Abstract][Full Text] [Related]
17. [Female pseudohermaphroditism. A propos of 2 cases].
Zmerli S; Maloum A; Sehairi K
J Urol Nephrol (Paris); 1972; 78(1):81-4. PubMed ID: 4341111
[No Abstract] [Full Text] [Related]
18. [Treatment of male adrenogenital syndrome (report of 17 cases)].
Liu GH; Li HZ; Li YQ; Ji ZG; Jin W; Li HJ
Zhonghua Nan Ke Xue; 2006 Jul; 12(7):633-5. PubMed ID: 16894944
[TBL] [Abstract][Full Text] [Related]
19. Catch-up growth in autosomal dominant isolated growth hormone deficiency (IGHD type II).
Binder G; Iliev DI; Mullis PE; Ranke MB
Growth Horm IGF Res; 2007 Jun; 17(3):242-8. PubMed ID: 17360215
[TBL] [Abstract][Full Text] [Related]
20. Final height in congenital adrenal hyperplasia due to 21-hydroxylase deficiency: the Italian experience.
Brunelli VL; Russo G; Bertelloni S; Gargantini L; Balducci R; Chiesa L; Livieri C; De Sanctis C; Einaudi S; Virdis R; Saggese G; Chiumello G
J Pediatr Endocrinol Metab; 2003 Mar; 16 Suppl 2():277-83. PubMed ID: 12729404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
